Title : Does lapatinib work against HER2-negative breast cancers?

Pub. Date : 2010 Mar 1

PMID : 20179241






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Interruption of HER2/ER cross-talk with lapatinib can restore sensitivity to anti-estrogens and thus, should be investigated in combination with endocrine therapy in patients with ER+/HER2-negative breast cancers. Lapatinib estrogen receptor 1 Homo sapiens